Pharmacy news, jobs, continuing education, community and more.
XenoPort to Present at the Deutsche Bank Annual Health Care Conference SANTA CLARA, Calif.–(BUSINESS WIRE)–XenoPort, Inc. (Nasdaq: XNPT) announced today that it will provide access via the World Wide Web to its presentation at the Deutsche Bank 37th Annual Health Care Conference. The live presentation will occur at 8:20 a.m. Pacific Time (11:20 a.m. Eastern [...]
Amylin Pharmaceuticals to Present at Deutsche Bank 37th Annual Health Care Conference SAN DIEGO–(BUSINESS WIRE)–Amylin Pharmaceuticals, Inc. (Nasdaq: AMLN) will be presenting at the Deutsche Bank 37th Annual Health Care Conference on Monday, May 7, 2012 at 2:10 p.m. ET / 11:10 a.m. PT in Boston. McKesson Reports Fiscal 2012 Fourth-Quarter and Full-Year Results SAN [...]
Merck Wins U.S. ZETIA® (ezetimibe)/ VYTORIN® (ezetimibe/simvastatin) Patent Infringement Lawsuit WHITEHOUSE STATION, N.J.–(BUSINESS WIRE)–Merck (NYSE: MRK), known as MSD outside the United States and Canada, announced today that the U.S. District Court for the District of New Jersey has ruled in Merck’s favor in two jointly related patent infringement suits against Mylan Pharmaceuticals Inc. “The [...]
Novartis announced today that the US Food and Drug Administration (FDA) approved Afinitor® (everolimus) tablets* for the treatment of adult patients with kidney tumors known as renal angiomyolipomas and tuberous sclerosis complex (TSC), who do not require immediate surgery[2]. This marks the first approval of a medical treatment in this patient population[2],[3]. The accelerated approval [...]
BioScrip to Host First Quarter 2012 Earnings Call ELMSFORD, N.Y.–(BUSINESS WIRE)–BioScrip (NASDAQ: BIOS) today announced that the Company will release its 2012 first quarter financial results before the market opens on Wednesday, May 9, 2012, and host a conference call at 8:30 a.m. Eastern Daylight Time (EDT) to discuss the results. Richard M. Smith, President [...]
Fitch Places Watson on Rating Watch Negative on Planned Acquisition of Actavis Group CHICAGO–(BUSINESS WIRE)–Fitch Ratings has placed the ratings for Watson Pharmaceuticals Inc. (Watson), including the ‘BBB’ Issuer Default Rating (IDR), on Rating Watch Negative. A complete list of ratings is provided at the end of this release. The ratings apply to approximately $1.1 [...]
Research and Markets: OTC Pharmaceuticals Market in Brazil Is Expected To Lead the Market to a Value of $5.8 Billion by the end of 2015 DUBLIN–(BUSINESS WIRE)–Research and Markets (http://www.researchandmarkets.com/research/jmp66j/otc_pharmaceutical) has announced the addition of the “OTC Pharmaceuticals in Brazil” report to their offering. OTC Pharmaceuticals in Brazil industry profile provides top-line qualitative and quantitative [...]
CHICAGO–(BUSINESS WIRE)–Fitch Ratings does not expect Pfizer’s Inc.’s (Pfizer) divestiture of its nutritionals business to Nestle S.A. (Nestle) for approximately $11.85 billion to materially affect the company’s current ratings and outlook. Fitch’s current ratings for Pfizer are: –Long-term Issuer Default Rating (IDR) of ‘A+; –Senior unsecured debt rating of ‘A+’; –Bank loan rating of ‘A+’; [...]
Affygility Solutions Announces Online Service for Potent Compound Safety OELs BROOMFIELD, Colo.–(BUSINESS WIRE)–OEL Fastrac, a simple an affordable way to obtain occupational exposure limits for active pharmaceutical ingredients. Visit affygility.com for more information. BioScrip Appoints Hai V. Tran as Senior Vice President, Chief Financial Officer and Treasurer ELMSFORD, N.Y.–(BUSINESS WIRE)–BioScrip, Inc. (NASDAQ: BIOS) (the “Company”) [...]
Featured Jobs
© Rx Times 2006 - 2012. All rights reserved. All products denoted with ™ and ® are trademarks or registered trademarks of Rx Times, LLC and/or its affiliates.